Mitsubishi UFJ Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $55.4K | Buy |
230
+170
| +283% | +$37.2K | ﹤0.01% | 1101 |
|
|
2026
Q1 | $11.3K | Hold |
60
| – | – | ﹤0.01% | 1356 |
|
|
2025
Q4 | $10.4K | Hold |
60
| – | – | ﹤0.01% | 1361 |
|
|
2025
Q3 | $7.91K | Hold |
60
| – | – | ﹤0.01% | 1385 |
|
|
2025
Q2 | $6.37K | Hold |
60
| – | – | ﹤0.01% | 1422 |
|
|
2025
Q1 | $7.45K | Hold |
60
| – | – | ﹤0.01% | 1364 |
|
|
2024
Q4 | $7.23K | Hold |
60
| – | – | ﹤0.01% | 1361 |
|
|
2024
Q3 | $6.68K | Hold |
60
| – | – | ﹤0.01% | 1357 |
|
|
2024
Q2 | $6.4K | Sell |
60
-33,159
| -100% | -$3.65M | ﹤0.01% | 1316 |
|
|
2024
Q1 | $4M | Buy |
33,219
+6,756
| +26% | +$828K | 0.01% | 672 |
|
|
2023
Q4 | $3.32M | Hold |
26,463
| – | – | 0.01% | 671 |
|
|
2023
Q3 | $3.43M | Buy |
26,463
+4,078
| +18% | +$543K | 0.01% | 658 |
|
|
2023
Q2 | $2.78M | Hold |
22,385
| – | – | 0.01% | 697 |
|
|
2023
Q1 | $3.28M | Buy |
22,385
+3,103
| +16% | +$459K | 0.01% | 654 |
|
|
2022
Q4 | $3.01M | Buy |
19,282
+26
| +0.1% | +$3.81K | 0.01% | 651 |
|
|
2022
Q3 | $2.57M | Buy |
19,256
+2,793
| +17% | +$425K | 0.01% | 662 |
|
|
2022
Q2 | $2.57M | Buy |
16,463
+2,259
| +16% | +$348K | 0.01% | 661 |
|
|
2022
Q1 | $2.21M | Sell |
14,204
-213
| -1% | -$30.9K | 0.01% | 714 |
|
|
2021
Q4 | $1.89M | Buy |
14,417
+1,199
| +9% | +$158K | 0.01% | 767 |
|
|
2021
Q3 | $1.72M | Buy |
13,218
+252
| +2% | +$38.1K | 0.01% | 761 |
|
|
2021
Q2 | $2.3M | Buy |
12,966
+1,215
| +10% | +$210K | 0.01% | 714 |
|
|
2021
Q1 | $1.93M | Buy |
11,751
+1,061
| +10% | +$175K | 0.01% | 695 |
|
|
2020
Q4 | $1.76M | Buy |
10,690
+794
| +8% | +$118K | 0.01% | 672 |
|
|
2020
Q3 | $1.41M | Buy |
9,896
+973
| +11% | +$121K | 0.01% | 658 |
|
|
2020
Q2 | $985K | Buy |
8,923
+750
| +9% | +$82.9K | 0.01% | 686 |
|
|
2020
Q1 | $815K | Sell |
8,173
-1,133
| -12% | -$146K | 0.01% | 657 |
|
|
2019
Q4 | $1.36M | Buy |
9,306
+1,260
| +16% | +$171K | 0.02% | 638 |
|
|
2019
Q3 | $1.03M | Sell |
8,046
-54
| -0.7% | -$7.24K | 0.02% | 616 |
|
|
2019
Q2 | $1.16M | Buy |
8,100
+806
| +11% | +$108K | 0.02% | 601 |
|
|
2019
Q1 | $1.04M | Buy |
7,294
+153
| +2% | +$20K | 0.02% | 572 |
|
|
2018
Q4 | $900K | Sell |
7,141
-401
| -5% | -$59.5K | 0.02% | 554 |
|
|
2018
Q3 | $1.27M | Buy |
7,542
+508
| +7% | +$87.4K | 0.03% | 539 |
|
|
2018
Q2 | $1.21M | Buy |
7,034
+100
| +1% | +$16.3K | 0.03% | 538 |
|
|
2018
Q1 | $1.05M | Sell |
6,934
-1,309
| -16% | -$192K | 0.02% | 565 |
|
|
2017
Q4 | $1.15M | Buy |
8,243
+202
| +3% | +$28K | 0.02% | 560 |
|
|
2017
Q3 | $1.18M | Buy |
8,041
+171
| +2% | +$25.9K | 0.03% | 534 |
|
|
2017
Q2 | $1.22M | Sell |
7,870
-1,068
| -12% | -$163K | 0.03% | 520 |
|
|
2017
Q1 | $1.3M | Sell |
8,938
-34
| -0.4% | -$4.43K | 0.03% | 532 |
|
|
2016
Q4 | $1M | Buy |
8,972
+210
| +2% | +$23.4K | 0.02% | 582 |
|
|
2016
Q3 | $1.06M | Buy |
8,762
+167
| +2% | +$22.5K | 0.03% | 550 |
|
|
2016
Q2 | $1.22M | Buy |
8,595
+226
| +3% | +$33.3K | 0.03% | 483 |
|
|
2016
Q1 | $1.09M | Buy |
8,369
+679
| +9% | +$84.5K | 0.03% | 513 |
|
|
2015
Q4 | $1.08M | Buy |
7,690
+590
| +8% | +$81.8K | 0.03% | 500 |
|
|
2015
Q3 | $943K | Sell |
7,100
-123
| -2% | -$21.2K | 0.03% | 518 |
|
|
2015
Q2 | $1.27M | Sell |
7,223
-358
| -5% | -$64.3K | 0.04% | 469 |
|
|
2015
Q1 | $1.31M | Sell |
7,581
-455
| -6% | -$78.1K | 0.04% | 482 |
|
|
2014
Q4 | $1.31M | Buy |
+8,036
| New | +$1.33M | 0.04% | 467 |
|
Other funds holding JAZZ
Mitsubishi UFJ Asset Management's JAZZ Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 283% in Q2 2026, buying an estimated $37.2K and bringing the position to 230 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.
Mitsubishi UFJ Asset Management first reported a position in JAZZ in Q4 2014 and has held it in 47 quarters since. The position peaked at $4M in Q1 2024. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Mitsubishi UFJ Asset Management held 230 shares of Jazz Pharmaceuticals worth $55.4K as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 170 Jazz Pharmaceuticals shares in Q2 2026, an estimated $37.2K.
- Jazz Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1101 holding.
- Mitsubishi UFJ Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
- Mitsubishi UFJ Asset Management's Jazz Pharmaceuticals position peaked at $4M in Q1 2024.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.